Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
pantoprazole (pantoprazole sodium sesquihydrate)
Advance Pharma GmbH
pantoprazole (pantoprazole sodium sesquihydrate)
40mg
tablets gastro-resistant
Prescription
_Panto-Denk 40_ Gastro-resistant tablet – oral use Active substance: pantoprazole Proton pump inhibitor PACKAGE LEAFLET: INFORMATION FOR THE USER READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. – Keep this leaflet. You may need to read it again. – If you have any further questions, ask your doctor or pharmacist – This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. – If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharma- cist. IN THIS LEAFLET: 1. What Panto-Denk 40 is and what it is used for 2. Before you take Panto-Denk 40 3. How to take Panto-Denk 40 4. Possible side effects 5. How to store Panto-Denk 40 6. Further information 1. WHAT PANTO-DENK 40 IS AND WHAT IT IS USED FOR Panto-Denk 40 is a medicine that reduces the production of stomach acid (selective proton pump inhibitor). PANTO-DENK 40 IS USED – to treat duodenal ulcers, – to treat stomach ulcers, – to treat moderate and severe forms of reflux oesophagitis (inflammation of the gullet), – for the long-term treatment of conditions asso- ciated with excess stomach acid production (e.g. Zollinger-Ellison syndrome), – in combination with antibiotics in the treat- ment of an infection caused by _Helicobacter_ _pylori._ This is a bacterial infection, which can cause inflammation of the stomach. It can also cause ulcers in the stomach or duodenum. Treating _Helicobacter pylori_ infection helps to heal these conditions and prevent them from returning. 2. BEFORE YOU TAKE PANTO-DENK 40 DO NOT TAKE PANTO-DENK 40 – if you are allergic (hypersensitive) to panto - prazole, soya, peanuts or any of the other ingredients of Panto-Denk 40, – if you are taking medicines with the active substance atazanavir (used to treat HIV in - fections). – in combined therapy of _Helicobacter pylori,_ when you suffer from moderate or severely reduced kidney or liver functi Read the complete document
Page: 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Panto-Denk 40 _ _ _ _ 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 gastro-resistant tablet contains 40 mg pantoprazole (equivalent to 45.1 mg pantoprazole sodium 1.5 H 2 O). Excipients: 1 tablet contains 76.85 mg maltitol (see section 4.4). For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Gastro-resistant tablets Yellow, oval tablet. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Duodenal ulcer - Gastric ulcer - Moderate and severe forms of reflux oesophagitis - Long-term treatment of Zollinger-Ellison syndrome and other disorders associated with pathological hypersecretion of gastric acid - Eradication of _Helicobacter pylori_ , in combination with antibiotics in patients with duodenal ulcer or gastric ulcer 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ADULTS AND ADOLESCENTS AGED 12 YEARS AND OLDER _ _ Moderate and severe forms of reflux oesophagitis The recommended dose for reflux oesophagitis is 1 Panto-Denk 40 gastro-resistant tablet dai- ly. In individual cases, especially in patients yet to respond to therapy with other medicinal prod- ucts, the dose can be doubled (i.e. 2 Panto-Denk 40 gastro-resistant tablets daily). ADULTS Page: 2 of 11 Gastric and duodenal ulcers For monotherapy with Panto-Denk 40, the following dosing guidelines apply: For gastroduodenal ulcers, the dose is 1 Panto-Denk 40 gastro-resistant tablet daily. In individual cases, especially in patients yet to respond to therapy with other medicinal prod- ucts, the double dose can be given (an increase to 2 Panto-Denk 40 gastro-resistant tablets daily). Zollinger-Ellison syndrome For the long-term therapy of Zollinger-Ellison syndrome and other disorders associated with pathological hypersecretion of gastric acid, the recommended starting dose is 80 mg daily (2 Panto-Denk 40 tablets).Thereafter, the dosage can be individually adjusted to the extent of gastric acid secretion. At dosages of more than 80 mg daily, the daily dose should be Read the complete document